Neuralgia Treatment Market Size, Share & Trends Analysis Report By Treatment (Drug Based, Surgery), By End Use (Hospital & Clinics, Ambulatory Surgery Centers), By Region, And Segment Forecasts, 2020 - 2027
- Report ID: GVR-4-68039-022-8
- Number of Pages: 114
- Format: Electronic (PDF)
- Historical Range: 2016 - 2018
- Industry: Healthcare
Market Segmentation
- Neuralgia Treatment Outlook (Revenue, USD Million, 2016 - 2027)
- Drug Based
- Anticonvulsant Medicines
- Tricyclic Antidepressants
- Surgery
- Radiofrequency Thermal Lesioning
- Stereotactic Radiosurgery
- Microvascular Decompression
- Others
- Drug Based
- Neuralgia Treatment End-use Outlook (Revenue, USD Million, 2016 - 2027)
- Hospital & Clinics
- Ambulatory Surgery Centers
- Others
- Neuralgia Treatment Regional Outlook (Revenue, USD Million, 2016 - 2027)
- North America
- North America neuralgia treatment market, by treatment
- Drug Based
- Anticonvulsant Medicines
- Tricyclic Antidepressants
- Surgery
- Radiofrequency Thermal Lesioning
- Stereotactic Radiosurgery
- Microvascular Decompression
- Others
- Drug Based
- North America neuralgia treatment market, by end use
- Hospital & Clinics
- Ambulatory Surgery Centers
- Others
- The U.S.
- The U.S. neuralgia treatment market, by treatment
- Drug Based
- Anticonvulsant Medicines
- Tricyclic Antidepressants
- Surgery
- Radiofrequency Thermal Lesioning
- Stereotactic Radiosurgery
- Microvascular Decompression
- Others
- Drug Based
- The U.S. neuralgia treatment market, by end use
- Hospital & Clinics
- Ambulatory Surgery Centers
- Others
- The U.S. neuralgia treatment market, by treatment
- Canada
- Canada neuralgia treatment market, by treatment
- Drug Based
- Anticonvulsant Medicines
- Tricyclic Antidepressants
- Surgery
- Radiofrequency Thermal Lesioning
- Stereotactic Radiosurgery
- Microvascular Decompression
- Others
- Drug Based
- Canada neuralgia treatment market, by end use
- Hospital & Clinics
- Ambulatory Surgery Centers
- Others
- Canada neuralgia treatment market, by treatment
- North America neuralgia treatment market, by treatment
- Europe
- Europe neuralgia treatment market, by treatment
- Drug Based
- Anticonvulsant Medicines
- Tricyclic Antidepressants
- Surgery
- Radiofrequency Thermal Lesioning
- Stereotactic Radiosurgery
- Microvascular Decompression
- Others
- Drug Based
- Europe neuralgia treatment market, by end use
- Hospital & Clinics
- Ambulatory Surgery Centers
- Others
- Germany
- Germany neuralgia treatment market, by treatment
- Drug Based
- Anticonvulsant Medicines
- Tricyclic Antidepressants
- Surgery
- Radiofrequency Thermal Lesioning
- Stereotactic Radiosurgery
- Microvascular Decompression
- Others
- Drug Based
- Germany neuralgia treatment market, by end use
- Hospital & Clinics
- Ambulatory Surgery Centers
- Others
- Germany neuralgia treatment market, by treatment
- The U.K.
- The U.K. neuralgia treatment market, by treatment
- Drug Based
- Anticonvulsant Medicines
- Tricyclic Antidepressants
- Surgery
- Radiofrequency Thermal Lesioning
- Stereotactic Radiosurgery
- Microvascular Decompression
- Others
- Drug Based
- The U.K. neuralgia treatment market, by end use
- Hospital & Clinics
- Ambulatory Surgery Centers
- Others
- The U.K. neuralgia treatment market, by treatment
- Europe neuralgia treatment market, by treatment
- Asia Pacific
- Asia Pacific neuralgia treatment market, by treatment
- Drug Based
- Anticonvulsant Medicines
- Tricyclic Antidepressants
- Surgery
- Radiofrequency Thermal Lesioning
- Stereotactic Radiosurgery
- Microvascular Decompression
- Others
- Drug Based
- Asia Pacific neuralgia treatment market, by end use
- Hospital & Clinics
- Ambulatory Surgery Centers
- Others
- Japan
- Japan neuralgia treatment market, by treatment
- Drug Based
- Anticonvulsant Medicines
- Tricyclic Antidepressants
- Surgery
- Radiofrequency Thermal Lesioning
- Stereotactic Radiosurgery
- Microvascular Decompression
- Others
- Drug Based
- Japan neuralgia treatment market, by end use
- Hospital & Clinics
- Ambulatory Surgery Centers
- Others
- Japan neuralgia treatment market, by treatment
- China
- China neuralgia treatment market, by treatment
- Drug Based
- Anticonvulsant Medicines
- Tricyclic Antidepressants
- Surgery
- Radiofrequency Thermal Lesioning
- Stereotactic Radiosurgery
- Microvascular Decompression
- Others
- Drug Based
- China neuralgia treatment market, by end use
- Hospital & Clinics
- Ambulatory Surgery Centers
- Others
- China neuralgia treatment market, by treatment
- Asia Pacific neuralgia treatment market, by treatment
- Latin America
- Latin America neuralgia treatment market, by treatment
- Drug Based
- Anticonvulsant Medicines
- Tricyclic Antidepressants
- Surgery
- Radiofrequency Thermal Lesioning
- Stereotactic Radiosurgery
- Microvascular Decompression
- Others
- Drug Based
- Latin America neuralgia treatment market, by end use
- Hospital & Clinics
- Ambulatory Surgery Centers
- Others
- Brazil
- Brazil neuralgia treatment market, by treatment
- Drug Based
- Anticonvulsant Medicines
- Tricyclic Antidepressants
- Surgery
- Radiofrequency Thermal Lesioning
- Stereotactic Radiosurgery
- Microvascular Decompression
- Others
- Drug Based
- Brazil neuralgia treatment market, by end use
- Hospital & Clinics
- Ambulatory Surgery Centers
- Others
- Brazil neuralgia treatment market, by treatment
- Mexico
- Mexico neuralgia treatment market, by treatment
- Drug Based
- Anticonvulsant Medicines
- Tricyclic Antidepressants
- Surgery
- Radiofrequency Thermal Lesioning
- Stereotactic Radiosurgery
- Microvascular Decompression
- Others
- Drug Based
- Mexico neuralgia treatment market, by end use
- Hospital & Clinics
- Ambulatory Surgery Centers
- Others
- Mexico neuralgia treatment market, by treatment
- Latin America neuralgia treatment market, by treatment
- Middle East & Africa
- Middle East & Africa neuralgia treatment market, by treatment
- Drug Based
- Anticonvulsant Medicines
- Tricyclic Antidepressants
- Surgery
- Radiofrequency Thermal Lesioning
- Stereotactic Radiosurgery
- Microvascular Decompression
- Others
- Drug Based
- Middle East & Africa neuralgia treatment market, by end use
- Hospital & Clinics
- Ambulatory Surgery Centers
- Others
- South Africa
- South Africa neuralgia treatment market, by treatment
- Drug Based
- Anticonvulsant Medicines
- Tricyclic Antidepressants
- Surgery
- Radiofrequency Thermal Lesioning
- Stereotactic Radiosurgery
- Microvascular Decompression
- Others
- Drug Based
- South Africa neuralgia treatment market, by end use
- Hospital & Clinics
- Ambulatory Surgery Centers
- Others
- South Africa neuralgia treatment market, by treatment
- Saudi Arabia
- Saudi Arabia neuralgia treatment market, by treatment
- Drug Based
- Anticonvulsant Medicines
- Tricyclic Antidepressants
- Surgery
- Radiofrequency Thermal Lesioning
- Stereotactic Radiosurgery
- Microvascular Decompression
- Others
- Drug Based
- Saudi Arabia neuralgia treatment market, by end use
- Hospital & Clinics
- Ambulatory Surgery Centers
- Others
- Saudi Arabia neuralgia treatment market, by treatment
- Middle East & Africa neuralgia treatment market, by treatment
- North America
Report content
Qualitative Analysis
- Industry overview
- Industry trends
- Market drivers and restraints
- Market size
- Growth prospects
- Porter’s analysis
- PESTEL analysis
- Key market opportunities prioritized
- Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments
Quantitative Analysis
- Market size, estimates, and forecast from 2016 to 2027
- Market estimates and forecast for product segments up to 2027
- Regional market size and forecast for product segments up to 2027
- Market estimates and forecast for application segments up to 2027
- Regional market size and forecast for application segments up to 2027
- Company financial performance
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
